Prostaglandin synthesis linked to phosphatidylinositol turnover in isolated rat glomeruli

Vaughn Wesley Folkert, Marc Yunis, Detlef Schlondorff

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Prostaglandins produced by the glomerulus are important factors in controlling glomerular function. The controlling step, i.e., the release of arachidonic acid from the phospholipids by either phospholipase A2 and/or C, remains poorly defined. The present studies were designed to determine which factors control arachidonic acid turnover and prostaglandin synthesis in glomeruli. As tools we used the calcium ionophore A23187, mepacrine, a phospholipase inhibitor, trifluoperazine, a calmodulin antagonist, and angiotensin II. A23187 (2 μM) caused a significant stimulation of both prostaglandin E2 and prostaglandin F synthesis (measured by radioimmunoassay), which was associated with increased phosphatidylinositol turnover (measured by [14C]arachidonic acid and [32P]orthophosphate incorporation). Surprisingly, trifluoperazine (10-100 μM) also progressively increased synthesis of both prostaglandins, which was accompanied by increased phosphatidic acid/phosphatidylinositol turnover and decreased phosphatidylinositol content. In contrast, phosphatidylcholine and phosphatidylethanolamine turnover were significantly inhibited by trifluoperazine and their total content remained unaffected. Mepacrine (1 mM) decreased prostaglandin synthesis and both phosphatidylcholine and phosphatidylethanolamine turnover, and had no consistent effect on phosphatidylinositol turnover in control glomeruli. Mepacrine did, however, inhibit both A23187 or trifluoperazine-induced increase in phosphatidylinositol turnover. Angiotensin II increased turnover of phosphatidylinositol and also phosphatidylcholine, as determined by incorporation of [14C]arachidonic acid. Thus, all agents that increased prostaglandin synthesis also enhanced phosphatidylinositol turnover. The exact pathway of arachidonic acid release remains to be determined.

Original languageEnglish (US)
Pages (from-to)206-217
Number of pages12
JournalBiochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism
Volume794
Issue number2
DOIs
StatePublished - Jul 6 1984

Fingerprint

Phosphatidylinositols
Prostaglandins
Rats
Trifluoperazine
Arachidonic Acid
Quinacrine
Calcimycin
Phosphatidylcholines
Angiotensin II
Phosphatidic Acids
Dinoprost
Calcium Ionophores
Phospholipases
Phospholipases A2
Type C Phospholipases
Calmodulin
Dinoprostone
Radioimmunoassay
Phospholipids
Phosphates

Keywords

  • (Rat kidney)
  • Arachidonate
  • Phosphatidylinositol turnover
  • Phospholipid
  • Prostaglandin synthesis

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Endocrinology

Cite this

Prostaglandin synthesis linked to phosphatidylinositol turnover in isolated rat glomeruli. / Folkert, Vaughn Wesley; Yunis, Marc; Schlondorff, Detlef.

In: Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, Vol. 794, No. 2, 06.07.1984, p. 206-217.

Research output: Contribution to journalArticle

@article{34b0e7ed1c70463fbf247fc30412aaea,
title = "Prostaglandin synthesis linked to phosphatidylinositol turnover in isolated rat glomeruli",
abstract = "Prostaglandins produced by the glomerulus are important factors in controlling glomerular function. The controlling step, i.e., the release of arachidonic acid from the phospholipids by either phospholipase A2 and/or C, remains poorly defined. The present studies were designed to determine which factors control arachidonic acid turnover and prostaglandin synthesis in glomeruli. As tools we used the calcium ionophore A23187, mepacrine, a phospholipase inhibitor, trifluoperazine, a calmodulin antagonist, and angiotensin II. A23187 (2 μM) caused a significant stimulation of both prostaglandin E2 and prostaglandin F2α synthesis (measured by radioimmunoassay), which was associated with increased phosphatidylinositol turnover (measured by [14C]arachidonic acid and [32P]orthophosphate incorporation). Surprisingly, trifluoperazine (10-100 μM) also progressively increased synthesis of both prostaglandins, which was accompanied by increased phosphatidic acid/phosphatidylinositol turnover and decreased phosphatidylinositol content. In contrast, phosphatidylcholine and phosphatidylethanolamine turnover were significantly inhibited by trifluoperazine and their total content remained unaffected. Mepacrine (1 mM) decreased prostaglandin synthesis and both phosphatidylcholine and phosphatidylethanolamine turnover, and had no consistent effect on phosphatidylinositol turnover in control glomeruli. Mepacrine did, however, inhibit both A23187 or trifluoperazine-induced increase in phosphatidylinositol turnover. Angiotensin II increased turnover of phosphatidylinositol and also phosphatidylcholine, as determined by incorporation of [14C]arachidonic acid. Thus, all agents that increased prostaglandin synthesis also enhanced phosphatidylinositol turnover. The exact pathway of arachidonic acid release remains to be determined.",
keywords = "(Rat kidney), Arachidonate, Phosphatidylinositol turnover, Phospholipid, Prostaglandin synthesis",
author = "Folkert, {Vaughn Wesley} and Marc Yunis and Detlef Schlondorff",
year = "1984",
month = "7",
day = "6",
doi = "10.1016/0005-2760(84)90147-4",
language = "English (US)",
volume = "794",
pages = "206--217",
journal = "Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids",
issn = "1388-1981",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Prostaglandin synthesis linked to phosphatidylinositol turnover in isolated rat glomeruli

AU - Folkert, Vaughn Wesley

AU - Yunis, Marc

AU - Schlondorff, Detlef

PY - 1984/7/6

Y1 - 1984/7/6

N2 - Prostaglandins produced by the glomerulus are important factors in controlling glomerular function. The controlling step, i.e., the release of arachidonic acid from the phospholipids by either phospholipase A2 and/or C, remains poorly defined. The present studies were designed to determine which factors control arachidonic acid turnover and prostaglandin synthesis in glomeruli. As tools we used the calcium ionophore A23187, mepacrine, a phospholipase inhibitor, trifluoperazine, a calmodulin antagonist, and angiotensin II. A23187 (2 μM) caused a significant stimulation of both prostaglandin E2 and prostaglandin F2α synthesis (measured by radioimmunoassay), which was associated with increased phosphatidylinositol turnover (measured by [14C]arachidonic acid and [32P]orthophosphate incorporation). Surprisingly, trifluoperazine (10-100 μM) also progressively increased synthesis of both prostaglandins, which was accompanied by increased phosphatidic acid/phosphatidylinositol turnover and decreased phosphatidylinositol content. In contrast, phosphatidylcholine and phosphatidylethanolamine turnover were significantly inhibited by trifluoperazine and their total content remained unaffected. Mepacrine (1 mM) decreased prostaglandin synthesis and both phosphatidylcholine and phosphatidylethanolamine turnover, and had no consistent effect on phosphatidylinositol turnover in control glomeruli. Mepacrine did, however, inhibit both A23187 or trifluoperazine-induced increase in phosphatidylinositol turnover. Angiotensin II increased turnover of phosphatidylinositol and also phosphatidylcholine, as determined by incorporation of [14C]arachidonic acid. Thus, all agents that increased prostaglandin synthesis also enhanced phosphatidylinositol turnover. The exact pathway of arachidonic acid release remains to be determined.

AB - Prostaglandins produced by the glomerulus are important factors in controlling glomerular function. The controlling step, i.e., the release of arachidonic acid from the phospholipids by either phospholipase A2 and/or C, remains poorly defined. The present studies were designed to determine which factors control arachidonic acid turnover and prostaglandin synthesis in glomeruli. As tools we used the calcium ionophore A23187, mepacrine, a phospholipase inhibitor, trifluoperazine, a calmodulin antagonist, and angiotensin II. A23187 (2 μM) caused a significant stimulation of both prostaglandin E2 and prostaglandin F2α synthesis (measured by radioimmunoassay), which was associated with increased phosphatidylinositol turnover (measured by [14C]arachidonic acid and [32P]orthophosphate incorporation). Surprisingly, trifluoperazine (10-100 μM) also progressively increased synthesis of both prostaglandins, which was accompanied by increased phosphatidic acid/phosphatidylinositol turnover and decreased phosphatidylinositol content. In contrast, phosphatidylcholine and phosphatidylethanolamine turnover were significantly inhibited by trifluoperazine and their total content remained unaffected. Mepacrine (1 mM) decreased prostaglandin synthesis and both phosphatidylcholine and phosphatidylethanolamine turnover, and had no consistent effect on phosphatidylinositol turnover in control glomeruli. Mepacrine did, however, inhibit both A23187 or trifluoperazine-induced increase in phosphatidylinositol turnover. Angiotensin II increased turnover of phosphatidylinositol and also phosphatidylcholine, as determined by incorporation of [14C]arachidonic acid. Thus, all agents that increased prostaglandin synthesis also enhanced phosphatidylinositol turnover. The exact pathway of arachidonic acid release remains to be determined.

KW - (Rat kidney)

KW - Arachidonate

KW - Phosphatidylinositol turnover

KW - Phospholipid

KW - Prostaglandin synthesis

UR - http://www.scopus.com/inward/record.url?scp=0021227933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021227933&partnerID=8YFLogxK

U2 - 10.1016/0005-2760(84)90147-4

DO - 10.1016/0005-2760(84)90147-4

M3 - Article

C2 - 6428457

AN - SCOPUS:0021227933

VL - 794

SP - 206

EP - 217

JO - Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

JF - Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

SN - 1388-1981

IS - 2

ER -